This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Leveraged ETFs That Are Up 25% Plus at Halfway Q4
by Sweta Killa
We have highlighted a few leveraged equity ETFs that have piled up more than 25% returns so far in the fourth quarter and could continue to be investors' darlings.
Best Leveraged ETF Areas of Last Week
by Sanghamitra Saha
These leveraged ETFs posted solid gains last week.
5 Leveraged ETFs That Gained More Than 20% in October
by Sweta Killa
We have highlighted five leveraged equity ETFs that piled up more than 20% returns in October and could continue to be investors' darlings.
S&P 500 Posts Best Week in 7 Years: 5 Best Leveraged ETFs
by Sweta Killa
The S&P 500 and Nasdaq Composite Index logged in the best week since 2011 on optimism over the U.S.-China trade truce and a dovish Fed view.
New Pharma ETF PILL : What Investors Need to Know
by Sanghamitra Saha
Inside the pros and cons of the pharma sector and chances of outperformance of the just-launched fund PILL.
5 Reasons Why Biotech ETFs are Soaring
by Sanghamitra Saha
Reasons that propelled the biotech space and the related ETFs higher.